|
As Senior Vice-President, Medical and Scientific Affairs, Dr. Peter Silverstone is responsible for the activities associated with the Clinical Development and Regulatory Affairs organizations. More specifically, he focuses on the rapid clinical development and the effective registration of Biovail's pipeline products. Dr. Silverstone joined Biovail in May 2006 from Global IQ, a clinical research organization that he co-founded in 1999. He served as Chief Medical Officer of Global IQ, and is also a professor in the Faculty of Medicine at the University of Alberta, Canada. Dr. Silverstone has more than 150 peer-reviewed publications and presentations. He has held leadership positions in the clinical research industry for over 10 years, and has participated as an active clinical investigator in more than 40 studies. Dr. Silverstone trained in medicine at the University of London, where he graduated in 1982. In 1989, he gained a Doctoral Fellowship there, and spent three years as a Research Fellow at the University of Oxford. He joined the University of Alberta, Canada in 1992, and is a Professor in the Departments of Psychiatry and Neuroscience. | 